國立高雄大學圖資館 |

Language: English

Back

Inflammatory pathways in diabetesbio...

Pugia, Michael.

Inflammatory pathways in diabetesbiomarkers and clinical correlates /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Inflammatory pathways in diabetesedited by Michael Pugia.
Reminder of title:	biomarkers and clinical correlates /
other author:	Pugia, Michael.
Published:	Cham :Springer International Publishing :2015.
Description:	xvi, 219 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Diabetes.
Online resource:	http://dx.doi.org/10.1007/978-3-319-21927-1
ISBN:	9783319219271$q(electronic bk.)

Inflammatory pathways in diabetesbiomarkers and clinical correlates /
Inflammatory pathways in diabetesbiomarkers and clinical correlates /[electronic resource] :edited by Michael Pugia. - Cham :Springer International Publishing :2015. - xvi, 219 p. :ill., digital ;24 cm. - Progress in inflammation research. - Progress in inflammation research..

Part 1. Introduction -- 1. Impact of inflammation and the innate immunity response in obesity mediated diabetes (lit review) -- Part 2. Impact of complement on diabetic disease -- 2. Complement and Complement Regulatory Proteins in Diabetes -- Part 3. Role of C terminal fragment of adiponectin receptor in inhibition of insulin degradation -- 3. Development of adiponectin receptor C terminal fragment bioassays -- 4. Protease inhibition and biological distribution of the C terminal fragment of adiponectin receptor -- 5. Cell & biological models for the C terminal fragment of adiponectin receptor -- 6. C-Terminal fragment of adiponectin receptor clinical correlations -- Part 4. Uristatin assay for prediction of renal and other clinical events -- 7. Uristatin immunoassay usage in glomerular nephritis assessment -- 8. Acute Response of Uristatin in Surgery -- 9. Cardiovascular and metabolic syndrome impact on uristatin -- 10. Uristatin anti-inflammatory cellular signaling -- Part 5. Summary -- 11. Overview of progress in new markers for diabetes inflammation (Literatue Review)

This book discusses recent advances in new anti- and pro-inflammatory pathways in diabetic disease, and identifies new diagnostic immunological methods that offer potential companion diagnostics for diabetic diseases. New methods in proteomics, mass spectroscopy, immunological assay design, measurement of cellular signal transduction and protease inhibition are used to clarify new biochemical pathways. Biomarker validation in animal models and correlations in humans for diagnostic clinical trials shed new light on the impact of diabetic diseases. The book reviews current understanding of inflammatory pathways in the pathophysiology of insulin resistance, metabolic syndrome, nephritis and other diabetic inflammatory conditions, and is the first to describe the impact of novel adipokines, protease inhibitors and complement markers. By presenting new methodologies for biomarker discovery, it provides a valuable resource for researchers studying clinical diagnosis, drug development, bio-analytical chemistry, proteomics and biochemistry. It is also useful for those conducting clinical and biological studies for targeted drug development. The methodologies and approaches can be applied to other markers, and the information will be helpful in the preparation of research grant applications.

ISBN: 9783319219271$q(electronic bk.)

Standard No.: 10.1007/978-3-319-21927-1doiSubjects--Topical Terms:

274215
Diabetes.

LC Class. No.: RC660

Dewey Class. No.: 616.462072

Inflammatory pathways in diabetesbiomarkers and clinical correlates /
LDR:03401nmm a2200325 a 4500 001 476360
003 DE-He213
005 20160411133208.0
006 m d
007 cr nn 008maaau
008 160526s2015 gw s 0 eng d
020 $a 9783319219271$q(electronic bk.)
020 $a 9783319219264$q(paper)
024 7 $a 10.1007/978-3-319-21927-1 $2 doi
035 $a 978-3-319-21927-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC660
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 616.462072 $2 23
090 $a RC660 $b .I43 2015
245 0 0 $a Inflammatory pathways in diabetes $h [electronic resource] : $b biomarkers and clinical correlates / $c edited by Michael Pugia.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xvi, 219 p. : $b ill., digital ; $c 24 cm.
490 1 $a Progress in inflammation research
505 0 $a Part 1. Introduction -- 1. Impact of inflammation and the innate immunity response in obesity mediated diabetes (lit review) -- Part 2. Impact of complement on diabetic disease -- 2. Complement and Complement Regulatory Proteins in Diabetes -- Part 3. Role of C terminal fragment of adiponectin receptor in inhibition of insulin degradation -- 3. Development of adiponectin receptor C terminal fragment bioassays -- 4. Protease inhibition and biological distribution of the C terminal fragment of adiponectin receptor -- 5. Cell & biological models for the C terminal fragment of adiponectin receptor -- 6. C-Terminal fragment of adiponectin receptor clinical correlations -- Part 4. Uristatin assay for prediction of renal and other clinical events -- 7. Uristatin immunoassay usage in glomerular nephritis assessment -- 8. Acute Response of Uristatin in Surgery -- 9. Cardiovascular and metabolic syndrome impact on uristatin -- 10. Uristatin anti-inflammatory cellular signaling -- Part 5. Summary -- 11. Overview of progress in new markers for diabetes inflammation (Literatue Review)
520 $a This book discusses recent advances in new anti- and pro-inflammatory pathways in diabetic disease, and identifies new diagnostic immunological methods that offer potential companion diagnostics for diabetic diseases. New methods in proteomics, mass spectroscopy, immunological assay design, measurement of cellular signal transduction and protease inhibition are used to clarify new biochemical pathways. Biomarker validation in animal models and correlations in humans for diagnostic clinical trials shed new light on the impact of diabetic diseases. The book reviews current understanding of inflammatory pathways in the pathophysiology of insulin resistance, metabolic syndrome, nephritis and other diabetic inflammatory conditions, and is the first to describe the impact of novel adipokines, protease inhibitors and complement markers. By presenting new methodologies for biomarker discovery, it provides a valuable resource for researchers studying clinical diagnosis, drug development, bio-analytical chemistry, proteomics and biochemistry. It is also useful for those conducting clinical and biological studies for targeted drug development. The methodologies and approaches can be applied to other markers, and the information will be helpful in the preparation of research grant applications.
650 0 $a Diabetes. $3 274215
650 0 $a Inflammation. $3 250775
650 0 $a Biochemical markers. $3 195446
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Immunology. $3 189152
650 2 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Metabolic Diseases. $3 274217
650 2 4 $a Biochemistry, general. $3 273649
700 1 $a Pugia, Michael. $3 730931
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Progress in inflammation research. $3 714471
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-21927-1
950 $a Biomedical and Life Sciences (Springer-11642)